Transcriptional Responses to Estrogen and Progesterone in Mammary Gland Identify Networks Regulating p53 Activity
Open Access
- 12 June 2008
- journal article
- other
- Published by The Endocrine Society in Endocrinology
- Vol. 149 (10), 4809-4820
- https://doi.org/10.1210/en.2008-0035
Abstract
Estrogen and progestins are essential for mammary growth and differentiation but also enhance the activity of the p53 tumor suppressor protein in the mammary epithelium. However, the pathways by which these hormones regulate p53 activity are unknown. Microarrays were used to profile the transcriptional changes within the mammary gland after administration of either vehicle, 17β-estradiol (E), or progesterone (P) individually and combined (EP). Treatment with EP yielded 1182 unique genes that were differentially expressed compared to the vehicle-treated group. Although 30% of genes were responsive to either E or P individually, combined treatment with both EP had a synergistic effect accounting for 60% of the differentially regulated genes. Analysis of protein-protein interactions identified p53, RelA, Snw1, and Igfals as common targets of genes regulated by EP. RelA and p53 form hubs within a network connected by genes that are regulated by EP and that may coordinate the competing functions of RelA and p53 in proliferation and survival of cells. Induction of early growth response 1 (Egr1) and Stratifin (Sfn) (also known as 14–3-3σ) by EP was confirmed by reverse transcription-quantitative PCR and shown to be p53 independent. In luciferase reporter assays, Egr1 was shown to enhance transcriptional activation by p53 and inhibit nuclear factor κB activity. These results identify a gene expression network that provides redundant activation of RelA to support proliferation as well as sensitize p53 to ensure proper surveillance and integration of their competing functions through factors such as Egr1, which both enhance p53 and inhibit RelA.Keywords
This publication has 69 references indexed in Scilit:
- IκB kinase α kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cellsProceedings of the National Academy of Sciences, 2007
- Estrogen receptor-α expression in the mammary epithelium is required for ductal and alveolar morphogenesis in miceProceedings of the National Academy of Sciences, 2007
- Phosphorylation of CBP by IKKα Promotes Cell Growth by Switching the Binding Preference of CBP from p53 to NF-κBMolecular Cell, 2007
- Synergistic effects of retinoic acid and tamoxifen on human breast cancer cells: Proteomic characterizationExperimental Cell Research, 2007
- Genome-wide analysis of estrogen receptor binding sitesNature Genetics, 2006
- Regulation of p53 tumour suppressor target gene expression by the p52 NF-κB subunitThe EMBO Journal, 2006
- The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFβ1, PTEN, p53, and fibronectinCancer Gene Therapy, 2005
- A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in HumansCell, 2004
- Stabilization of p53 Is a Novel Mechanism for Proapoptotic Function of NF-κBJournal of Biological Chemistry, 2004
- A radioautographic study of cell proliferation in the mammary gland of the pregnant mouseThe Anatomical Record, 1967